Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio
Open to Strategic Partnerships and Product Collaborations

Corporate Development

Upsher-Smith is proud of its heritage as a trusted name in pharmaceuticals.

Bolstered by the opening of our new 270,000 sq. ft. manufacturing facility, Plant C, Upsher-Smith is currently seeking partners with a solid history of success and a vision for future growth and innovation, who can help us expand our portfolio. We are specifically interested in opportunities to acquire, license or co-develop:

  • Diverse dosage forms of generic products across all indications
  • Niche generic products for orphan indications which could benefit from Upsher-Smith’s unique promotional strategies and specialty-pharmacy partnerships
  • Key focus on late-stage generic assets with launch potential within the next 2 years
  • Potential technical transfer opportunities for oral dosage forms to leverage our new state-of-the-art manufacturing facility

Together, we seek to deliver the best value for our mutual stakeholders, and most importantly, to Do More Good™ for the patients we serve.

Contact us at USLinfo@upsher-smith.com.

Partner Relations

Upsher-Smith Partners with NASPA to Honor Innovators in the Pharmacy Field

Upsher-Smith Partners with NASPA to Honor Innovators in the Pharmacy Field

The NASPA Excellence in Innovation Award recognizes and honors a qualified pharmacist who has demonstrated significant innovation in his or her respective practice, method, or service directly or indirectly resulting in improved patient care and/or advancement of the profession of pharmacy.

The award is presented annually by participating state pharmacist associations, including those in the District of Columbia and Puerto Rico.

NASPA Innovation Map
Careers

Join Our Team!

We’re hiring

Search Our Jobs

Close